Literature DB >> 25496724

Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Alexandre Vouga1, Ryan A Gregg1, Maryah Haidery2, Anita Ramnath2, Hassan K Al-Hassani2, Christopher S Tallarida1, David Grizzanti1, Robert B Raffa2, Garry R Smith3, Allen B Reitz3, Scott M Rawls4.   

Abstract

Knowledge about the neuropharmacology of mephedrone (MEPH) applies primarily to the racemate, or street form of the drug, but not to its individual enantiomers. Here, through chemical isolation of MEPH enantiomers and subsequent behavioral characterization in established invertebrate (planarian) assays, we began separating adverse effects of MEPH from potential therapeutic actions. We first compared stereotypical and environmental place conditioning (EPC) effects of racemic MEPH, S-MEPH, and R-MEPH. Stereotypy was enhanced by acute treatment (100-1000 μM) with each compound; however, S-MEPH was less potent and efficacious than racemate and R-MEPH. Both R-MEPH (10, 100, 250 μM) and racemate (100 μM) produced EPC, but S-MEPH was ineffective at all concentrations (10-100 μM). After showing that S-MEPH lacked rewarding efficacy, we investigated its ability to alter three of cocaine's behavioral effects (EPC, withdrawal, and stereotypy). Cocaine (1 μM) produced EPC that was abolished when S-MEPH (100 μM) was administered after cocaine conditioning. Spontaneous withdrawal from chronic cocaine exposure caused a reduction in motility that was not evident during acute or continuous cocaine treatment but was attenuated by S-MEPH (100 μM) treatment during the cocaine abstinence interval. Acute stereotypy produced by 1 mM cocaine, nicotine or racemic MEPH was not affected by S-MEPH (10-250 μM). The present results obtained using planarian assays suggest that the R-enantiomer of MEPH is predominantly responsible for its stimulant and rewarding effects and the S-enantiomer is capable of antagonizing cocaine's addictive-like behaviors without producing rewarding effects of its own.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Bath salt; Cathinone; Cocaine; Conditioned place preference; Enantiomer; Mephedrone; Planarians; Stereochemistry; Stereotypy; Withdrawal

Mesh:

Substances:

Year:  2014        PMID: 25496724      PMCID: PMC4418799          DOI: 10.1016/j.neuropharm.2014.11.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  70 in total

Review 1.  3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.

Authors:  M Coppola; R Mondola
Journal:  Toxicol Lett       Date:  2011-10-08       Impact factor: 4.372

2.  Mephedrone ("bath salt") pharmacology: insights from invertebrates.

Authors:  L Ramoz; S Lodi; P Bhatt; A B Reitz; C Tallarida; R J Tallarida; R B Raffa; S M Rawls
Journal:  Neuroscience       Date:  2012-01-20       Impact factor: 3.590

3.  A pharmacological study of cocaine activity in planaria.

Authors:  G Palladini; S Ruggeri; F Stocchi; M F De Pandis; G Venturini; V Margotta
Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol       Date:  1996-09

Review 4.  Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.

Authors:  L H Gold; M A Geyer; G F Koob
Journal:  NIDA Res Monogr       Date:  1989

5.  Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.

Authors:  J Kehr; F Ichinose; S Yoshitake; M Goiny; T Sievertsson; F Nyberg; T Yoshitake
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism.

Authors:  Suzan Owaisat; Robert B Raffa; Scott M Rawls
Journal:  Neurosci Lett       Date:  2012-08-03       Impact factor: 3.046

7.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

Authors:  Raul López-Arnau; Jose Martínez-Clemente; David Pubill; Elena Escubedo; Jorge Camarasa
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 8.  Imaging the neurochemistry of alcohol and substance abuse.

Authors:  Diana Martinez; Jong-Hoon Kim; John Krystal; Anissa Abi-Dargham
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

9.  Methcathione ("cat"): an enantiomeric potency comparison.

Authors:  R A Glennon; R Young; B R Martin; T A Dal Cason
Journal:  Pharmacol Biochem Behav       Date:  1995-04       Impact factor: 3.533

10.  Postnatal cocaine exposure: effects on behavior of rats in forced swim test.

Authors:  Ana Magalhães; Maria Amélia Tavares; Liliana de Sousa
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  5 in total

1.  Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.

Authors:  Helene L Philogene-Khalid; Callum Hicks; Allen B Reitz; Lee-Yuan Liu-Chen; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2017-06-13       Impact factor: 4.492

2.  Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: Implications for pain in planarian paroxysm etiology?

Authors:  Anthony Kim; Scott M Rawls
Journal:  Brain Res       Date:  2021-12-31       Impact factor: 3.252

3.  Stereoselective effects of the second-generation synthetic cathinone α-pyrrolidinopentiophenone (α-PVP): assessments of conditioned taste avoidance in rats.

Authors:  Katharine H Nelson; Raul López-Arnau; Briana J Hempel; Peter To; Hayley N Manke; Madeline E Crissman; Matthew M Clasen; Kenner C Rice; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2018-10-17       Impact factor: 4.530

4.  PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.

Authors:  Ashenafi Mebratu Zewde; Frances Yu; Sunil Nayak; Christopher Tallarida; Allen B Reitz; Lynn G Kirby; Scott M Rawls
Journal:  J Neurosci Methods       Date:  2017-10-16       Impact factor: 2.390

5.  Kratom pharmacology: Clues from planarians exposed to mitragynine.

Authors:  Sarah Uddin; Sonita Wiah; Tony Kim; Mia N Watson; Tyra Jennings; Scott M Rawls
Journal:  Physiol Behav       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.